News & events
News
Aude Fahrer's work aims to activate the immune cells responsible for attacking cancer, in a simple, low cost way.
Alex Maier has been elected as a Fellow of the Australian Society for Parasitology.
They say leaders are born not made, but it seems the opposite is true for queen bees, according to a new study by researchers from The Australian National University (ANU) and Queen Mary University of London.
New research from The Australian National University (ANU) has drilled down to the molecular level to find similarities across six pharmaceutical drugs used in pain relief, dentist anaesthetic, and treatment of epilepsy, in a bid to find a way to reduce unwanted side-effects.
Linden Muellner-Wong has won a 2017 RSB Director's Prize in Honours.
Although significant advances in malaria control have been made in the past few decades, resistance to our current antimalarial drug repertoire threatens control efforts.
Events
DNA stability is a prerequisite in many of its applications, ranging from DNA-based vaccine, data storage to gene therapy. However, the existing strategies to enhance the DNA stability are ineffective and limited in scope.
Synthetic chemistry and synthetic biology offer complementary tools for manipulating the 3D architecture and function of biomolecules. I will outline two different projects that exemplify our hybrid chemical biology approach, highlighting divergent applications in catalysis and cancer therapy.
Associate Professor Kelly Roger's team has built a lattice light sheet microscope which was instrumental in the discovery that mitochondrial DNA is released during apoptosis through BAK and BAX pores in the outer mitochondrial membrane.
Malaria is a major global health problem, with 247 million cases and 619,000 deaths estimated in 2021. Antimalarial drugs are critical for malaria treatment and eradication efforts.